Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
START: Sorafenib and TACE in HCC
NCT00990860Phase 2Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Taipei Veterans General Hospital. Status: unknown.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00990860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00990860.